Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.

Abstract

Three randomized, clinical trials of the drug ranolazine relate to patients with symptomatic myocardial ischemia. A fourth randomized, controlled, clinical trial compares optimal medical therapy with percutaneous coronary intervention (PCI) plus medical therapy.

• Authors: C Richard Conti
• Journal: Clinical cardiology (Clin Cardiol) Vol. 31 Issue 7 Pg. 295-6 (Jul 2008) ISSN: 0160-9289 [Print] United States
• PMID: 18636470 (Publication Type: Editorial)
• Copyright: Copyright (c) 2008 Wiley Periodicals, Inc.

Chemical References

• Acetanilides
• Enzyme Inhibitors
• Piperazines
• Ranolazine

Topics

• Acetanilides (therapeutic use)
• Angina Pectoris (drug therapy)
• Angioplasty, Balloon, Coronary
• Chronic Disease
• Enzyme Inhibitors (therapeutic use)
• Humans
• Myocardial Infarction (drug therapy)
• Myocardial Ischemia (drug therapy)
• Piperazines (therapeutic use)
• Randomized Controlled Trials as Topic
• Ranolazine